Showing results (161-170 of 2,508) with videos related to

Sort By:
Pageof 251
Clinical Lymphoma, Myeloma & Leukemia|December 30, 2019
Pharmacogenetic Variants in MTHFR Gene are Significant Predictors of Methotrexate Toxicities in Bangladeshi Patients With Acute Lymphoblastic LeukemiaFatema Tuz Zahra, Noor Ahmed Nahid, Md Reazul Islam, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 25, 2018
Systematic Literature Review of Treatment Options and Clinical Outcomes for Patients With Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic LeukemiaJill A Bell, Aaron Galaznik, Rachel Huelin, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 27, 2018
Outcomes of Adolescents and Young Adults With Acute Myeloid Leukemia Treated in a Single Latin American CenterJosé Carlos Jaime-Pérez, José Ramón Padilla-Medina, Lucía Teresa Fernández, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 27, 2018
Azacitidine Use for Myeloid NeoplasmsRiad El Fakih, Rami Komrokji, Marwan Shaheen, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 20, 2018
A Comparison of the Efficacy of Immunomodulatory-containing Regimens in Relapsed/Refractory Multiple Myeloma: A Network Meta-analysisMeletios Athanasios Dimopoulos, Jonathan L Kaufman, Darrell White, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 14, 2018
Marrow Hypocellularity, But Not Residual Blast Count or Receipt of Reinduction Chemotherapy, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia Patients With Morphologic Residual DiseaseThomas A Ollila, Adam J Olszewski, James N Butera, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 7, 2018
Prognostic Biomarkers in the Progression From MGUS to Multiple Myeloma: A Systematic ReviewCharlotte Cosemans, Bénedith Oben, Ingrid Arijs, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 10, 2018
Prognostic Prediction Model for Second Allogeneic Stem-Cell Transplantation in Patients With Relapsed Acute Myeloid Leukemia: Single-Center ReportSung-Soo Park, Hee-Je Kim, Kyoung Il Min, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 10, 2018
Efficacy of Ponatinib Versus Earlier Generation Tyrosine Kinase Inhibitors for Front-line Treatment of Newly Diagnosed Philadelphia-positive Acute Lymphoblastic LeukemiaElias Jabbour, Maral DerSarkissian, Mei Sheng Duh, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 5, 2016
Post-Transplantation Natural Killer Cell Count: A Predictor of Acute Graft-Versus-Host Disease and Survival Outcomes After Allogeneic Hematopoietic Stem Cell TransplantationSeo Yeon Kim, Hyewon Lee, Mi-Soon Han, et al.
Pageof 251